<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144523">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01782885</url>
  </required_header>
  <id_info>
    <org_study_id>BI13-001</org_study_id>
    <nct_id>NCT01782885</nct_id>
  </id_info>
  <brief_title>In Vivo and in Vitro Evaluation of PRP Therapy</brief_title>
  <official_title>In Vivo and in Vitro Evaluation of the Platelet-rich Plasma Treatment in Osteoarthritis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Dr. Jose E. Gonzalez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Dr. Jose E. Gonzalez</source>
  <oversight_info>
    <authority>Mexico: Research Ethics Committee from Facultad de Medicina and Hospital Universitario Dr. Jose Eleuterio Gonzalez</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test whether the platelet-rich plasma (PRP)intra-articular
      injection therapy is effective as an alternative treatment option in patients with mild knee
      osteoarthritis within a controlled randomized study. The investigators will evaluate
      patients outcome in level of pain and  quality of life at 3, 6 and 12 months follow up. The
      investigators will also analyze  the biochemical environment in patient's joint before and
      after the treatment.

      The study will be complemented with in vitro experiments of human osteoarthritic cartilage
      explants culture (and treated with PRP) for histological and gene expression assays.

      PRP intra-articular injections therapy is effective in patients with mild knee
      osteoarthritis by modifying the biochemical joint environment and cartilage regeneration
      capability.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Western Ontario and McMaster Universities Arthritis Index (WOMAC)</measure>
    <time_frame>0, 1 1/2, 3, 6, 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The WOMAC evaluation will be performed on patients who received the treatment at 0, 1 1/2, 3, 6 and 12 months after treatment finished.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Visual Analog Scale (VAS)</measure>
    <time_frame>0, 1 1/2, 3, 6, 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The VAS evaluation will be performed on patients who received the treatment at 0, 1 1/2, 3, 6 and 12 months after treatment finished.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in SF-12v2 Health Survey</measure>
    <time_frame>0, 3, 6, 12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The SF-12v2 Health Survey will be performed on patients who received the treatment at 0, 3, 6 and 12 months after treatment finished.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Osteoarthritis Grade I and II (Kellgren-Lawrence Scale)</condition>
  <arm_group>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients from this arm will receive a dosis of acetaminophen (500 mg/8 hours) while PRP treatment lasts.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intra-articular injection of PRP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients from this arm will receive 3 intra-articular knee injections of autologous platelet-rich plasma, one injection every two weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intra-articular injection of PRP</intervention_name>
    <description>Patients from this arm will receive 3 intra-articular knee injections of autologous platelet-rich plasma, one injection every two weeks.</description>
    <arm_group_label>Intra-articular injection of PRP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Older than 18 years old

          -  Patients who haven't received steroids injection or medical treatment 1 month before
             the study

          -  Patients with knee osteoarthritis grade I and II (Kellgren-Lawrence scale)

          -  Indistinct gender

          -  Patients who accept to participate in the study with previous signed informed consent

        Exclusion Criteria:

          -  Patients with knee osteoarthritis grade III and IV (Kellgren-Lawrence scale)

          -  Patients with prosthesis

          -  Pregnancy

          -  Patients with rheumatic diseases

          -  Patients with diabetes, hepatic diseases, coagulopathy, cardiovascular diseases,
             immunosuppression, infections

          -  Patients taking anticoagulants

          -  Patients with concentrations of hemoglobin under 11 g/dL and platelets under
             150,000/uL
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mario A. Simental, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Autónoma de Nuevo León, Facultad de Medicina</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Felix Vilchez, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José E. González</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Herminia G Martínez, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Universidad Autónoma de Nuevo León, Facultad de Medicina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Felix Vilchez, PhD</last_name>
    <phone>+52 (81) 8346 2310</phone>
    <email>vilchez.doctor@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Dr. José E. González</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo León</state>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mario A. Simental, MSc</last_name>
      <email>mario.simental@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Felix Vilchez, PhD</last_name>
      <email>vilchez.doctor@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mario A. Simental, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Felix Vilchez, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Spaková T, Rosocha J, Lacko M, Harvanová D, Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil. 2012 May;91(5):411-7. doi: 10.1097/PHM.0b013e3182aab72.</citation>
    <PMID>22513879</PMID>
  </reference>
  <reference>
    <citation>Filardo G, Kon E, Pereira Ruiz MT, Vaccaro F, Guitaldi R, Di Martino A, Cenacchi A, Fornasari PM, Marcacci M. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc. 2012 Oct;20(10):2082-91. Epub 2011 Dec 28.</citation>
    <PMID>22203046</PMID>
  </reference>
  <reference>
    <citation>van Buul GM, Koevoet WL, Kops N, Bos PK, Verhaar JA, Weinans H, Bernsen MR, van Osch GJ. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes. Am J Sports Med. 2011 Nov;39(11):2362-70. doi: 10.1177/0363546511419278. Epub 2011 Aug 19.</citation>
    <PMID>21856929</PMID>
  </reference>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 31, 2014</lastchanged_date>
  <firstreceived_date>January 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Dr. Jose E. Gonzalez</investigator_affiliation>
    <investigator_full_name>Mario Alberto Simental Mendia, M Sc, Principal Investigator</investigator_full_name>
    <investigator_title>M. Sc.</investigator_title>
  </responsible_party>
  <keyword>Osteoarthritis</keyword>
  <keyword>Platelet-Rich Plasma</keyword>
  <keyword>Intra-articular</keyword>
  <keyword>Injection</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
